Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2026-02-18 @ 12:23 PM
Study NCT ID:
NCT03317457
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2017-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Sponsor:
AIO-Studien-gGmbH
Organization: